Copyright Reports & Markets. All rights reserved.

Global Platinum Anti-tumor Drugs Market Size, Status and Forecast 2021-2027

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Platinum Anti-tumor Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
    • 1.2.2 Cisplatin
    • 1.2.3 Oxaliplatin
    • 1.2.4 Carboplatin
    • 1.2.5 Other
  • 1.3 Market by Application
    • 1.3.1 Global Platinum Anti-tumor Drugs Market Share by Application: 2016 VS 2021 VS 2027
    • 1.3.2 Colorectal Cancer
    • 1.3.3 Ovarian Cancer
    • 1.3.4 Lung Cancer
    • 1.3.5 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Platinum Anti-tumor Drugs Market Perspective (2016-2027)
  • 2.2 Platinum Anti-tumor Drugs Growth Trends by Regions
    • 2.2.1 Platinum Anti-tumor Drugs Market Size by Regions: 2016 VS 2021 VS 2027
    • 2.2.2 Platinum Anti-tumor Drugs Historic Market Share by Regions (2016-2021)
    • 2.2.3 Platinum Anti-tumor Drugs Forecasted Market Size by Regions (2022-2027)
  • 2.3 Platinum Anti-tumor Drugs Industry Dynamic
    • 2.3.1 Platinum Anti-tumor Drugs Market Trends
    • 2.3.2 Platinum Anti-tumor Drugs Market Drivers
    • 2.3.3 Platinum Anti-tumor Drugs Market Challenges
    • 2.3.4 Platinum Anti-tumor Drugs Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Platinum Anti-tumor Drugs Players by Revenue
    • 3.1.1 Global Top Platinum Anti-tumor Drugs Players by Revenue (2016-2021)
    • 3.1.2 Global Platinum Anti-tumor Drugs Revenue Market Share by Players (2016-2021)
  • 3.2 Global Platinum Anti-tumor Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Platinum Anti-tumor Drugs Revenue
  • 3.4 Global Platinum Anti-tumor Drugs Market Concentration Ratio
    • 3.4.1 Global Platinum Anti-tumor Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Platinum Anti-tumor Drugs Revenue in 2020
  • 3.5 Platinum Anti-tumor Drugs Key Players Head office and Area Served
  • 3.6 Key Players Platinum Anti-tumor Drugs Product Solution and Service
  • 3.7 Date of Enter into Platinum Anti-tumor Drugs Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Platinum Anti-tumor Drugs Breakdown Data by Type

  • 4.1 Global Platinum Anti-tumor Drugs Historic Market Size by Type (2016-2021)
  • 4.2 Global Platinum Anti-tumor Drugs Forecasted Market Size by Type (2022-2027)

5 Platinum Anti-tumor Drugs Breakdown Data by Application

  • 5.1 Global Platinum Anti-tumor Drugs Historic Market Size by Application (2016-2021)
  • 5.2 Global Platinum Anti-tumor Drugs Forecasted Market Size by Application (2022-2027)

6 North America

  • 6.1 North America Platinum Anti-tumor Drugs Market Size (2016-2027)
  • 6.2 North America Platinum Anti-tumor Drugs Market Size by Type
    • 6.2.1 North America Platinum Anti-tumor Drugs Market Size by Type (2016-2021)
    • 6.2.2 North America Platinum Anti-tumor Drugs Market Size by Type (2022-2027)
    • 6.2.3 North America Platinum Anti-tumor Drugs Market Size by Type (2016-2027)
  • 6.3 North America Platinum Anti-tumor Drugs Market Size by Application
    • 6.3.1 North America Platinum Anti-tumor Drugs Market Size by Application (2016-2021)
    • 6.3.2 North America Platinum Anti-tumor Drugs Market Size by Application (2022-2027)
    • 6.3.3 North America Platinum Anti-tumor Drugs Market Size by Application (2016-2027)
  • 6.4 North America Platinum Anti-tumor Drugs Market Size by Country
    • 6.4.1 North America Platinum Anti-tumor Drugs Market Size by Country (2016-2021)
    • 6.4.2 North America Platinum Anti-tumor Drugs Market Size by Country (2022-2027)
    • 6.4.3 United States
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Platinum Anti-tumor Drugs Market Size (2016-2027)
  • 7.2 Europe Platinum Anti-tumor Drugs Market Size by Type
    • 7.2.1 Europe Platinum Anti-tumor Drugs Market Size by Type (2016-2021)
    • 7.2.2 Europe Platinum Anti-tumor Drugs Market Size by Type (2022-2027)
    • 7.2.3 Europe Platinum Anti-tumor Drugs Market Size by Type (2016-2027)
  • 7.3 Europe Platinum Anti-tumor Drugs Market Size by Application
    • 7.3.1 Europe Platinum Anti-tumor Drugs Market Size by Application (2016-2021)
    • 7.3.2 Europe Platinum Anti-tumor Drugs Market Size by Application (2022-2027)
    • 7.3.3 Europe Platinum Anti-tumor Drugs Market Size by Application (2016-2027)
  • 7.4 Europe Platinum Anti-tumor Drugs Market Size by Country
    • 7.4.1 Europe Platinum Anti-tumor Drugs Market Size by Country (2016-2021)
    • 7.4.2 Europe Platinum Anti-tumor Drugs Market Size by Country (2022-2027)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific Platinum Anti-tumor Drugs Market Size (2016-2027)
  • 8.2 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Type
    • 8.2.1 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Type (2016-2021)
    • 8.2.2 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Type (2022-2027)
    • 8.2.3 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Type (2016-2027)
  • 8.3 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Application
    • 8.3.1 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Application (2016-2021)
    • 8.3.2 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Application (2022-2027)
    • 8.3.3 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Application (2016-2027)
  • 8.4 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region
    • 8.4.1 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region (2016-2021)
    • 8.4.2 Asia-Pacific Platinum Anti-tumor Drugs Market Size by Region (2022-2027)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Platinum Anti-tumor Drugs Market Size (2016-2027)
  • 9.2 Latin America Platinum Anti-tumor Drugs Market Size by Type
    • 9.2.1 Latin America Platinum Anti-tumor Drugs Market Size by Type (2016-2021)
    • 9.2.2 Latin America Platinum Anti-tumor Drugs Market Size by Type (2022-2027)
    • 9.2.3 Latin America Platinum Anti-tumor Drugs Market Size by Type (2016-2027)
  • 9.3 Latin America Platinum Anti-tumor Drugs Market Size by Application
    • 9.3.1 Latin America Platinum Anti-tumor Drugs Market Size by Application (2016-2021)
    • 9.3.2 Latin America Platinum Anti-tumor Drugs Market Size by Application (2022-2027)
    • 9.3.3 Latin America Platinum Anti-tumor Drugs Market Size by Application (2016-2027)
  • 9.4 Latin America Platinum Anti-tumor Drugs Market Size by Country
    • 9.4.1 Latin America Platinum Anti-tumor Drugs Market Size by Country (2016-2021)
    • 9.4.2 Latin America Platinum Anti-tumor Drugs Market Size by Country (2022-2027)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Platinum Anti-tumor Drugs Market Size (2016-2027)
  • 10.2 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Type
    • 10.2.1 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Type (2016-2021)
    • 10.2.2 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Type (2022-2027)
    • 10.2.3 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Type (2016-2027)
  • 10.3 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Application
    • 10.3.1 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Application (2016-2021)
    • 10.3.2 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Application (2022-2027)
    • 10.3.3 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Application (2016-2027)
  • 10.4 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country
    • 10.4.1 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country (2016-2021)
    • 10.4.2 Middle East & Africa Platinum Anti-tumor Drugs Market Size by Country (2022-2027)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 Sanofi
    • 11.1.1 Sanofi Company Details
    • 11.1.2 Sanofi Business Overview
    • 11.1.3 Sanofi Platinum Anti-tumor Drugs Introduction
    • 11.1.4 Sanofi Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.1.5 Sanofi Recent Development
  • 11.2 Hengrui Medicine
    • 11.2.1 Hengrui Medicine Company Details
    • 11.2.2 Hengrui Medicine Business Overview
    • 11.2.3 Hengrui Medicine Platinum Anti-tumor Drugs Introduction
    • 11.2.4 Hengrui Medicine Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.2.5 Hengrui Medicine Recent Development
  • 11.3 ASK Pharma
    • 11.3.1 ASK Pharma Company Details
    • 11.3.2 ASK Pharma Business Overview
    • 11.3.3 ASK Pharma Platinum Anti-tumor Drugs Introduction
    • 11.3.4 ASK Pharma Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.3.5 ASK Pharma Recent Development
  • 11.4 Yi Bai Pharmaceutical
    • 11.4.1 Yi Bai Pharmaceutical Company Details
    • 11.4.2 Yi Bai Pharmaceutical Business Overview
    • 11.4.3 Yi Bai Pharmaceutical Platinum Anti-tumor Drugs Introduction
    • 11.4.4 Yi Bai Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.4.5 Yi Bai Pharmaceutical Recent Development
  • 11.5 Qilu Pharmaceutical
    • 11.5.1 Qilu Pharmaceutical Company Details
    • 11.5.2 Qilu Pharmaceutical Business Overview
    • 11.5.3 Qilu Pharmaceutical Platinum Anti-tumor Drugs Introduction
    • 11.5.4 Qilu Pharmaceutical Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.5.5 Qilu Pharmaceutical Recent Development
  • 11.6 Teva
    • 11.6.1 Teva Company Details
    • 11.6.2 Teva Business Overview
    • 11.6.3 Teva Platinum Anti-tumor Drugs Introduction
    • 11.6.4 Teva Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.6.5 Teva Recent Development
  • 11.7 Pfizer
    • 11.7.1 Pfizer Company Details
    • 11.7.2 Pfizer Business Overview
    • 11.7.3 Pfizer Platinum Anti-tumor Drugs Introduction
    • 11.7.4 Pfizer Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.7.5 Pfizer Recent Development
  • 11.8 Dr Reddy's Laboratories
    • 11.8.1 Dr Reddy's Laboratories Company Details
    • 11.8.2 Dr Reddy's Laboratories Business Overview
    • 11.8.3 Dr Reddy's Laboratories Platinum Anti-tumor Drugs Introduction
    • 11.8.4 Dr Reddy's Laboratories Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.8.5 Dr Reddy's Laboratories Recent Development
  • 11.9 Mylan
    • 11.9.1 Mylan Company Details
    • 11.9.2 Mylan Business Overview
    • 11.9.3 Mylan Platinum Anti-tumor Drugs Introduction
    • 11.9.4 Mylan Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.9.5 Mylan Recent Development
  • 11.10 Sun Pharma
    • 11.10.1 Sun Pharma Company Details
    • 11.10.2 Sun Pharma Business Overview
    • 11.10.3 Sun Pharma Platinum Anti-tumor Drugs Introduction
    • 11.10.4 Sun Pharma Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.10.5 Sun Pharma Recent Development
  • 11.11 Novartis
    • 11.11.1 Novartis Company Details
    • 11.11.2 Novartis Business Overview
    • 11.11.3 Novartis Platinum Anti-tumor Drugs Introduction
    • 11.11.4 Novartis Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.11.5 Novartis Recent Development
  • 11.12 Debiopharm
    • 11.12.1 Debiopharm Company Details
    • 11.12.2 Debiopharm Business Overview
    • 11.12.3 Debiopharm Platinum Anti-tumor Drugs Introduction
    • 11.12.4 Debiopharm Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.12.5 Debiopharm Recent Development
  • 11.13 Accord Healthcare
    • 11.13.1 Accord Healthcare Company Details
    • 11.13.2 Accord Healthcare Business Overview
    • 11.13.3 Accord Healthcare Platinum Anti-tumor Drugs Introduction
    • 11.13.4 Accord Healthcare Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.13.5 Accord Healthcare Recent Development
  • 11.14 SK Chemicals
    • 11.14.1 SK Chemicals Company Details
    • 11.14.2 SK Chemicals Business Overview
    • 11.14.3 SK Chemicals Platinum Anti-tumor Drugs Introduction
    • 11.14.4 SK Chemicals Revenue in Platinum Anti-tumor Drugs Business (2016-2021)
    • 11.14.5 SK Chemicals Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Platinum Anti-tumor Drugs Scope and Market Size
    Platinum Anti-tumor Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Platinum Anti-tumor Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

    Segment by Type
    Cisplatin
    Oxaliplatin
    Carboplatin
    Other

    Segment by Application
    Colorectal Cancer
    Ovarian Cancer
    Lung Cancer
    Other

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia
    Latin America
    Mexico
    Brazil
    Rest of Latin America
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of MEA

    By Company
    Sanofi
    Hengrui Medicine
    ASK Pharma
    Yi Bai Pharmaceutical
    Qilu Pharmaceutical
    Teva
    Pfizer
    Dr Reddy's Laboratories
    Mylan
    Sun Pharma
    Novartis
    Debiopharm
    Accord Healthcare
    SK Chemicals

    Buy now